Abstract OT3-02-10: Nordic trip, a randomized phase 3 study in early triple negative breast cancerNiklas Loman, Henrik Lindman, OT Johannsson et al.|Cancer Research|2016Cited by 3
468 Individually dose-adjusted treatment with epirubicin and paclitaxel with or without capecitabine as 1st line treatment in metastatic breast cancer. A randomized multicenter trialThomas Hatschek, Martina Sundqvist, Zakaria Einbeigi et al.|European Journal of Cancer Supplements|2010Cited by 1